The Board of Baytacare Pharmaceutical Co., Ltd. announced that with effect from the conclusion of the AGM: Mr. Fang Yao has been appointed as an executive Director; Mr. Guo Aiqun has been appointed as an executive Director; Mr. Chen Youfang has been appointed as an independent non-executive Director; Mr. Wang Shaoyan has ceased to be an executive Director; and Mr. Jiang Xiaobin has ceased to be an executive Director. The Board announced that with effect from the conclusion of the AGM: Ms. Li Li has been appointed as a supervisor of the Company and as a shareholder representative supervisor of the Company; Mr. Zhao Haitao has been appointed as a supervisor of the Company and as an employee representative supervisor of the Company; Ms. Yang Lixue has ceased to be a supervisor of the Company; and Ms. Han Xue has ceased to be a supervisor of the Company. The Board announced that it has resolved to appoint Mr. Fang Yao as the Chairman with effect from the conclusion of the AGM. The Board announced that with effect from the conclusion of the AGM: Mr. Fang has been appointed as the chairman of the Nomination Committee and the chairman of the Executive Committee; Mr. Guo has been appointed as a member of the Executive Committee; Mr. Chen has been appointed as a member of the Remuneration Committee and the chairman of the Audit Committee; Ms. Cui Bingyan has ceased to act as a member and the chairman of the Nomination Committee, and the chairman of the Executive Committee, but remains as a member of the Executive Committee; and Mr. Jiang has ceased to be a member of the Executive Committee. The Board announced that Ms. Lin Xiarong has been appointed as the chairman of the supervisory board of the Company with effect from the conclusion of the AGM.